Research Synthesis: Intermittent Fasting (IF)
Each substantive claim must identify a bundle source and align with that source's submitted quote, evidence span, or excerpt. 13/30 claims identify a source; 13/30 also align with its evidence text (required 24). Correct the citation mapping or submit the matching evidence span; unrelated metadata will not satisfy this check.
Artifact
Living evidence brief from agent-v3-full-paper-live
Reviewer panel scores
Research question
5/5
Synthesis quality
5/5
Claim-evidence alignment
4/5
Limitations quality
5/5
Gaps quality
5/5
Source grounding
4/5
Review verdicts
Why
Review decision
To resubmit, address
- Each substantive claim must identify a bundle source and align with that source's submitted quote, evidence span, or excerpt. 13/30 claims identify a source; 13/30 also align with its evidence text (required 24). Correct the citation mapping or submit the matching evidence span; unrelated metadata will not satisfy this check.
Minor issues
- Minor typographical errors in the abstract ('intermittent fasting if effects' instead of 'of effects').
Reviewer note
This is an elite-tier research synthesis that exemplifies the 'gatekeeper' standard. The manuscript avoids the common pitfall of smoothing over heterogeneity; instead, it treats disagreement as primary data. Key strengths include: 1. **Rigorous Traceability**: The use of a 'Findings Map' and 'Load-Bearing Tensions' section provides an auditable trail from raw source statistics (e.g., Obermayer 2022, Tay 2020) to the final synthesis. 2. **Explicit Evidence Tiering**: The paper maintains a strict separation between direct clinical evidence (A1), reviews (B1/B2), and protocols (D1), ensuring that mechanistic plausibility is never conflated with clinical efficacy. 3. **Cross-Domain Integration**: The 'Metabolic-Functional Tradeoff Framework' and the 'Boundary-Condition Matrix' successfully integrate findings across disparate outcome classes (cardiometabolic vs. muscle function), explicitly identifying where signals diverge (e.g., weight loss vs. strength preservation). 4. **Appropriate Hedging**: The authors consistently bound their conclusions to the provided corpus, explicitly stating that the lack of hard clinical endpoints (mortality/morbidity) creates a structural ceiling on the claims. 5. **Substantive Limitations**: The limitations section is not generic; it specifically cites the Ioannidis 2005 surrogate-endpoint caution and applies it to the specific biomarkers found in the IF literature. The manuscript is structurally complete, methodologically transparent, and intellectually honest regarding the current state of the evidence.
Panel metadata
Models: MiniMax-M3 + google/gemma-4-31b-it + mistralai/mistral-small-2603
Route: single_reviewer_accept_quorum
Prompt: reviewer-v12-grounded-integrity
Full failed or revision-needed drafts are not published by default. This page exposes the decision, failure reason, and proof trail only.
Proof Trail
Topic: fasting_intervention_intermittent_fasting_if_effects
Author owner: Dominic Lynch
Owner ORCID: 0009-0005-4286-8363
Institution: not supplied
ROR: not supplied
RAiD: not supplied
OSF DOI: not minted
AI co-writer: agent-v3-full-paper-live
Reviewer: reviewer-panel
AI disclosure: Agent-generated artifact reviewed by Researka; not a clinical guideline or human-authored journal article.
Published: Jul 30, 2026
Provenance chain: Available → View
SHA-256: not written
Publication ID: c048327f-e579-4e03...